Erythrocyte membrane cholesterol and lipid core growth in a rabbit model of atherosclerosis: Modulatory effects of rosuvastatin

International Journal of Cardiology

Volumn 170, Issue 2, 2013, Pages 173-181

  Tziakas, Dimitrios ^a   Chalikias, Georgios ^a   Kapelouzou, Alkistis ^b   Tentes, Ioannis ^c   Schäfer, Katrin ^d   Karayannakos, Panagiotis ^b   Kostakis, Alkiviadis ^b   Boudoulas, Harissios ^b   Konstantinides, Stavros ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Atherosclerosis; Cholesterol; Erythrocyte membranes; Rabbits; Rosuvastatin

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOCHEMICAL COMPOSITION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL CONTENT OF ERYTHROCYTE MEMBRANE; CONCENTRATION (PARAMETERS); CONCENTRATION TIME INTEGRAL; CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; EXPERIMENTAL RABBIT; HEMODYNAMIC PARAMETERS; LIPID CORE EXPANSION; MALE; NONHUMAN; PRIORITY JOURNAL;

ATHEROSCLEROSIS; CHOLESTEROL; ERYTHROCYTE MEMBRANES; RABBITS; ROSUVASTATIN;

ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; ERYTHROCYTE MEMBRANE; FLUOROBENZENES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PLAQUE, ATHEROSCLEROTIC; PYRIMIDINES; RABBITS; SULFONAMIDES;

EID: 84889082608     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.10.070     Document Type: Article

References (32)

1. R. Virmani, A.P. Burke, A. Farb, and F.D. Kolodgie Pathology of the vulnerable plaque J Am Coll Cardiol 47 2006 C13 C18
2. M.J. Davies, P.D. Richardson, N. Woolf, D.R. Katz, and J. Mann Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content Br Heart J 69 1993 377 381
3. J.R. Guyton, and K.F. Klemp Development of the lipid-rich core in human atherosclerosis Arterioscler Thromb Vasc Biol 16 1996 4 11
4. R. Virmani, F.D. Kolodgie, and A.P. Burke Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage Atheroscler Thromb Vasc Biol 25 2005 2054 2061
5. P.L. Yeagle Cholesterol and the cell membrane Biochim Biophys Acta 822 1985 267 287
6. D. Tziakas, J.C. Kaski, and G.K. Chalikias Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome J Am Coll Cardiol 49 2007 2081 2089
7. C.C. Allain, L.S. Poon, C.S.G. Chan, W. Richmond, and P.C. Fu Enzymatic determination of total serum cholesterol Clin Chem 20 1974 470 475
8. H.L. Lin, L. Zhang, and C.X. Liu Haemin-enhanced expression of haem oxygenase-1 stabilizes erythrocyte-induced vulnerable atherosclerotic plaques Br J Pharmacol 160 2010 1484 1495
9. A. Melillo Rabbit clinical pathology J Exot Pet Med 16 2007 133 145
10. Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), A.L. Catapano, and Z. Reiner ESC Committee for Practice Guidelines 2008-2010 and 2010-2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Atherosclerosis 217 Suppl. 1 2011 S1 S44
11. R. Virmani, F.D. Kolodgie, A.P. Burke, A. Farb, and S.M. Schwartz Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions Arterioscler Thromb Vasc Biol 20 2000 1262 1275
12. F.D. Kolodgie, R. Virmani, and A.P. Burke Pathologic assessment of the vulnerable human coronary plaque Heart 90 2004 1385 1391
13. I. Tabas Cholesterol and phospholipid metabolism in macrophages Biochim Biophys Acta 1529 2000 164 174
14. F.D. Kolodgie, H.K. Gold, and A.P. Burke Intraplaque hemorrhage and progression of coronary atheroma N Engl J Med 349 2003 2316 2325
15. P.R. Moreno, K.R. Purushothaman, and V. Fuster Plaque neovascularization increased in ruptured atherosclerotic lesions of human aorta. Implications for plaque vulnerability Circulation 110 2004 2032 2038
16. M.M. Kockx, K.M. Cromheeke, and M.W. Knaapen Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis Arterioscler Thromb Vasc Biol 23 2003 440 446
17. J.B. Michel, R. Vrimani, E. Arbustini, and G. Pasterkamp Intraplaque hemorrhages as the trigger of plaque vulnerability Eur Heart J 32 2011 1977 1985
18. G.S. Abela, K. Aziz, A. Vedre, D.R. Pathak, J.D. Talbott, and J. Dejong Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes Am J Cardiol 103 2009 959 968
19. P. Duewell, H. Kono, and K.J. Rayner NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals Nature 464 2010 1357 1361
20. K. Rajamaki, J. Lappalainen, and K. Oorni Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation PLoS ONE 5 2010 e11765
21. G. Kellner-Weibel, W.G. Jerome, and D.M. Small Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death Arterioscler Thromb Vasc Biol 18 1998 423 431
22. G. Balla, H.S. Jacob, J.W. Eaton, J.D. Belcher, and G.M. Vercellotti Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury Arterioscler Thromb 11 1991 1700 1711
23. D.N. Tziakas, G.K. Chalikias, D. Stakos, and H. Boudoulas The role of red blood cells in the progression and instability of atherosclerotic plaque Int J Cardiol 142 2010 2 7
24. E. Arbustini, P. Morbini, and A.M. D'Armini Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of the thrombotic material in pultaceous core formation Heart 88 2002 177 182
25. H.L. Lin, X.-S. Xu, and H.-X. Lu Pathological mechanisms and dose dependency of erythrocyte-induced vulnerability of atherosclerotic plaques J Mol Cell Cardiol 43 2007 272 280
26. N. Takaya, C. Yuan, and B. Chu Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study Circulation 111 2005 2768 2775
27. G.D. Giannoglou, K.C. Koskinas, and D.N. Tziakas Total cholesterol content of erythrocyte membranes and coronary atherosclerosis: an intravascular ultrasound pilot study Angiology 60 2010 676 682
28. D.N. Tziakas, G.K. Chalikias, and D. Stakos Statin use is associated with a significant reduction in cholesterol content of erythrocyte membranes. A novel pleiotropic effect? Cardiovasc Drugs Ther 23 2009 471 480
29. M. Martinez, A. Vaya, and R. Marti Erythrocyte membrane cholesterol/phospolipid changes and haemorrheological modifications in familial hypercholesterolemia treated with lovastatin Thromb Res 83 1996 375 388
30. M. Koter, M. Brochel, J. Chojnowska-Jezierska, K. Klikczynska, and I. Franiak The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia Eur J Clin Pharmacol 58 2002 501 506
31. F.D. Kolodgie, A.S. Katocs Jr., and E.E. Largis Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type Arterioscler Thromb Vasc Biol 16 1996 1454 1464
32. M.A. Latour, B.W. Patterson, R.T. Kitchens, R.E. Ostlund Jr., D. Hopkins, and G. Schonfeld Effects of alcohol and cholesterol feeding on lipoprotein metabolism and cholesterol absorption in rabbits Arterioscler Thromb Vasc Biol 19 1999 598 604